Search for: "CIPLA"
Results 101 - 120
of 202
Sorted by Relevance
|
Sort by Date
15 Jan 2013, 11:49 am
Cipla has always been appealing to the Indian government to modify its intellectual property laws to safeguard Indian consumers from monopoly. [read post]
18 Feb 2013, 12:46 am
Yusuf Hamied is the Chairman of Cipla and, is also known as the Grand Old Man of the Indian Pharmaceuticals Industry. [read post]
21 Sep 2010, 7:47 pm
– Peanut based malnutrition treatment – humanitarian developments and compulsory licensing (IP finance) NGOs warn on IP in Trans Pacific Trade Agreement (IP Watch) Africa: African traditional knowledge and folklore given IP protection despite warning of TK commodification (IP Watch) Brazil, EU, India, Netherlands: Consultations on WTO drug transit case continue (IP Watch) EU: Vaccines causing trouble once more… Georgetown University referral to ECJ concerning SPC Regulation (The… [read post]
19 Feb 2009, 12:13 am
Why Cipla's counsel argued the Court to disregard the IPO finding in favor of Roche? [read post]
19 Feb 2008, 3:39 am
3 Apr 2012, 8:57 pm
The case of Adcock Ingram v Cipla Medpro reconsidered the notion that pharmaceuticals sold on prescription are less likely to be confused because they are dispensed by trained professionals in regulated circumstances. [read post]
16 Aug 2013, 7:48 pm
Some of the biggest violators of the Drug Price Control Order (DPCO) have been Indian generics like Cipla. [read post]
4 Mar 2013, 10:29 pm
Cipla's sale does not aid Bayers' case in any way, particularly since Bayer sued Cipla for infringement. [read post]
14 Aug 2023, 4:30 am
For South Africa, cases examined are: Soobramoney v Minister of Health; Minister of Health & Ors v Treatment Action Campaign & Others (No. 2); and Minister of Health v New Clicks, which deal with the interpretation and effect of constitutional provisions on the right of access to health care services; and Pfizer v Cipla MedPro; and Aventis v Cipla, which deal with the tension between patent rights and the right to health.However, in the judicial policymaking process, Oke… [read post]
11 Mar 2015, 9:15 am
Roche filed an infringement suit against Cipla in Delhi High Court in January 2008. [read post]
30 Nov 2006, 8:18 pm
Cipla and Ranbaxy Laboratories, Indian generic drug manufacturers, will be providing pills that combine three antiretroviral drugs into a single tablet, a formulation that is easier to transport, store and use than multiple pills and syrups. [read post]
14 Mar 2012, 6:40 am
Bayer argued that Cipla's sales should be considered when deciding whether the reasonable requirements of the public were being satisfied (even though Cipla were being sued by Bayer for these actions). [read post]
15 Sep 2010, 2:40 am
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic Vancocin; alleges… [read post]
29 Jun 2011, 3:34 am
(Patent Docs) Deferacirox – India: Cipla wins pre grant opposition (593/CHENP/2005): Novartis v. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
2 Oct 2007, 3:44 am
., et al. (09/05/2007): appeal of order of district court entering judgment upholding the vailidity of reissue patent-in-suit and enjoining Ivax and Cipla from infringing the patent (affirmed, but injunction modified); discussion of patent related to an antidepressant composition (U.S. [read post]
18 Aug 2010, 12:19 am
Les Laboratoires Servier (No 2) (Patentology) India: Post grant oppositions – new decisions: Richter v Cipla; Novartis v Cipla (Generic Pharmaceuticals and IP) Mexico: COFEMER and AMELAF comment on Biotech Regulations in Mexico (Patent Docs) US: American Bar Association files amicus brief in Therasense case (Patent Docs) US: Biopolymer Engineering and MIT fail to get vacation (of summary judgment): Biopolymer Engineering and MIT v. [read post]
17 Feb 2010, 5:10 am
(IP Whiteboard) EU: European Commission probes for evidence of foul play among pharmaceutical companies (IP Whiteboard) EU / UK: Of conflict and cooperation: when national courts and the EPO differ: Eli Lilly and Company v Human Genome Sciences (PatLit) India: Drug makers decry Indian patent law (GenericsWeb) India: India-EU gets flak in India (GenericsWeb) India: Delhi High Court: Rejection of application based on pre-grant representation may be appealed to IPAB: UCB Farchim SA v Cipla… [read post]
17 Dec 2008, 9:57 pm
In past Patent Circle exclusively brought in notice couple of patents issued to Cipla for new forms of known drugs, namely, esomeprazole and alendronate and accused Cipla of practicing double standards on patenting so-called trivial improvements. [read post]
25 Apr 2006, 11:04 am
Generic or copycat versions of Combivir are available in India from drug-makers such as Cipla, Ranbaxy, Aurobindo, Emcure and Strides. [read post]
